Literature DB >> 32250603

Mannosylated Poly(ethylene imine) Copolymers Enhance saRNA Uptake and Expression in Human Skin Explants.

Anna K Blakney1, Yamin Abdouni2, Gokhan Yilmaz3, Renjie Liu2, Paul F McKay1, Clément R Bouton1, Robin J Shattock1, C Remzi Becer2,4.   

Abstract

Messenger RNA (mRNA) is a promising platform for both vaccines and therapeutics, and self-amplifying RNA (saRNA) is particularly advantageous, as it enables higher protein expression and dose minimization. Here, we present a delivery platform for targeted delivery of saRNA using mannosylated poly(ethylene imine) (PEI) enabled by the host-guest interaction between cyclodextrin and adamantane. We show that the host-guest complexation does not interfere with the electrostatic interaction with saRNA and observed that increasing the degree of mannosylation inhibited transfection efficiency in vitro, but enhanced the number of cells expressing GFP by 8-fold in human skin explants. Besides, increasing the ratio of glycopolymer to saRNA also enhanced the percentage of transfected cells ex vivo. We identified that these mannosylated PEIs specifically increased protein expression in the epithelial cells resident in human skin in a mannose-dependent manner. This platform is promising for further study of glycosylation of PEI and targeted saRNA delivery.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32250603     DOI: 10.1021/acs.biomac.0c00445

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  7 in total

1.  Formulation and Delivery Technologies for mRNA Vaccines.

Authors:  Chunxi Zeng; Chengxiang Zhang; Patrick G Walker; Yizhou Dong
Journal:  Curr Top Microbiol Immunol       Date:  2020-06-02       Impact factor: 4.291

Review 2.  Harnessing molecular recognition for localized drug delivery.

Authors:  Renjie Liu; Ran Zuo; Gregory A Hudalla
Journal:  Adv Drug Deliv Rev       Date:  2021-01-20       Impact factor: 15.470

Review 3.  mRNA vaccines manufacturing: Challenges and bottlenecks.

Authors:  Sara Sousa Rosa; Duarte M F Prazeres; Ana M Azevedo; Marco P C Marques
Journal:  Vaccine       Date:  2021-03-24       Impact factor: 4.169

Review 4.  An Update on Self-Amplifying mRNA Vaccine Development.

Authors:  Anna K Blakney; Shell Ip; Andrew J Geall
Journal:  Vaccines (Basel)       Date:  2021-01-28

Review 5.  The nano delivery systems and applications of mRNA.

Authors:  Mingyuan Li; Yuan Li; Shiqin Li; Lin Jia; Haomeng Wang; Meng Li; Jie Deng; Ali Zhu; Liqiao Ma; Weihong Li; Peng Yu; Tao Zhu
Journal:  Eur J Med Chem       Date:  2021-10-08       Impact factor: 6.514

Review 6.  Applications and challenges of biomaterial mediated mRNA delivery.

Authors:  Huapan Fang; Qian Chen
Journal:  Explor Target Antitumor Ther       Date:  2022-08-31

Review 7.  Self-amplifying RNA vaccines for infectious diseases.

Authors:  Kristie Bloom; Fiona van den Berg; Patrick Arbuthnot
Journal:  Gene Ther       Date:  2020-10-22       Impact factor: 5.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.